Want to Monitor Medicare's New Drug Benefit Program? Start by Sending a Check for $120,000
Medicare Part D is a bold experiment in the public/private provision of health insurance. Both researchers and beneficiaries need access to data to see if it works, but the government is stonewalling, according to Dana Goldman and Daniel McFadden.
McFadden Daniel L, Goldman Dana P
core
Hyperuricemia Reflects Cardiometabolic Burden Rather than Left Ventricular Systolic Dysfunction Across Heart Failure Phenotypes: Insights from a Real-World Acute Heart Failure Cohort. [PDF]
Ibănescu R +11 more
europepmc +1 more source
Human-Induced Downsizing of Animal Communities Weakens Trait Matching Between Tropical Plants and Frugivores. [PDF]
Guerra D +6 more
europepmc +1 more source
Scoping Review of Global Kidney Genetics Clinic Models and Outcomes. [PDF]
Lim RS +15 more
europepmc +1 more source
Integrated veterinary practices and farm performance of small ruminants. [PDF]
Ziba D +4 more
europepmc +1 more source
T-bet-expressing Tr1 cells driven by dietary signals dominate the small intestinal immune landscape. [PDF]
Ansaldo E +10 more
europepmc +1 more source
Key strategies to reduce the global burden of myopia: consensus from the international myopia summit. [PDF]
Eppenberger LS +11 more
europepmc +1 more source
Computing with electromagnetic fields rather than binary digits: a route towards artificial general intelligence and conscious AI. [PDF]
McFadden J.
europepmc +1 more source

